One Drop Acquires Sano

0
45
One Drop | Real-TIme Glucose Forecasts

One Drop has announced that it has acquired the assets and intellectual property of Sano Intelligence, Inc which includes Sano’s continuous glucose sensing platform. This deal means that One Drop will now own all of Sanso’s asset and several Sano team members will be joining One Drop.

What’s One Drop? One Drop is a Digital Health company with a focus on global transforming the lives of people with diabetes and chronic conditions via the power of mobile computing and data science.

Its platform has allowed individuals, employers, insurers and health care providers to access evidence-based and affordable offers. This achieved through its proprietary machine learning, advanced AI and personal health coaching which also promotes positive behavioural changes and outcomes.

What’s Sano? Sano is a continuous glucose sensing platform, developed back in the 2010’s.

What’s Next? One Drop intends to continue Sano’s comprehensive multi-sensorial solutions. This means it will continue its efforts to bring personalized, adaptive, integrated health solutions to people in real-time via your mobile phones.

“Sano and One Drop have a shared vision of transforming traditional healthcare into proactive, preventative self-care,” said Sano CEO and founder, Ashwin Pushpala. “We are excited to combine our sensor and device expertise with the strength of One Drop’s data-driven predictive capabilities and user-centered design to create a comprehensive collision avoidance system for health and wellness.”

It will leverage Sano’s silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.

One Drop is the perfect acquirer of Sanos given the company has to date collected over 9 billion longitudinal health data points across 75 biomarkers from nearly 2.5 million users. It plans to add thousands of new data points per user per day, thereby strengthening the machine learning models behind One Drop’s predictive and adaptive support capabilities across multiple conditions.

An added perfect fit is the fact that One Drop continues to grow its diabetes solution to offer data-driven tools and personalized support for people living with type 1 diabetes, type 2 diabetes, gestational diabetes, prediabetes, high blood pressure, high cholesterol, or any combination of these conditions. 

Press Release

NEW YORK, April 13, 2020 /PRNewswire/ — One Drop, a leader in digital care solutions for people living with diabetes and other chronic conditions, today announced it has acquired all of the assets and intellectual property of Sano Intelligence, Inc., an innovator in health sensing technology. The deal was structured as an asset purchase, and several Sano team members will be joining One Drop.

The almost decade of work put into developing the Sano continuous glucose sensing platform will live on in a comprehensive multi-sensorial solution from One Drop. The planned development marks a significant milestone in One Drop’s effort to bring personalized, adaptive, integrated health solutions to people in real time via their mobile phones.

One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.

“Sano and One Drop have a shared vision of transforming traditional healthcare into proactive, preventative self-care,” said Sano CEO and founder, Ashwin Pushpala. “We are excited to combine our sensor and device expertise with the strength of One Drop’s data-driven predictive capabilities and user-centered design to create a comprehensive collision avoidance system for health and wellness.”

To date, One Drop has collected 9 billion longitudinal health data points across 75 biomarkers from nearly 2.5 million users. One Drop’s continuous health sensing platform will add thousands of new data points per user per day, thereby strengthening the machine learning models behind One Drop’s predictive and adaptive support capabilities across multiple conditions.

“Telehealth and digital self-management of chronic conditions are more important than ever, and the benefits of real-time health sensing are obvious,” said One Drop CEO and founder, Jeff Dachis. “By introducing continuous health sensing technology to One Drop’s personalized solutions for a rapidly growing variety of health issues, we can empower people to make informed, proactive choices and prevent problems before they happen.”

One Drop has expanded its diabetes solution to offer data-driven tools and personalized support for people living with type 1 diabetes, type 2 diabetes, gestational diabetes, prediabetes, high blood pressure, high cholesterol, or any combination of these conditions. At the same time, One Drop has supplemented its direct-to-consumer channels by introducing end-to-end employer and payor offerings, digital-only offerings, and broader retail availability to reach even larger populations. The company’s unique approach combines personal health coaching, connected devices, and AI-powered Predictive Insights to inspire positive behavior change.